title: Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes.
abstract: Respiratory syncytial virus (RSV) invades host cells via a type I fusion (F) glycoprotein that undergoes dramatic structural rearrangements during the fusion process. Neutralizing monoclonal antibodies, such as 101F, palivizumab, and motavizumab, target two major antigenic sites on the RSV F glycoprotein. The structures of these sites as peptide complexes with motavizumab and 101F have been previously determined, but a structure for the trimeric RSV F glycoprotein ectodomain has remained elusive. To address this issue, we undertook structural and biophysical studies on stable ectodomain constructs. Here, we present the 2.8-Å crystal structure of the trimeric RSV F ectodomain in its postfusion conformation. The structure revealed that the 101F and motavizumab epitopes are present in the postfusion state and that their conformations are similar to those observed in the antibody-bound peptide structures. Both antibodies bound the postfusion F glycoprotein with high affinity in surface plasmon resonance experiments. Modeling of the antibodies bound to the F glycoprotein predicts that the 101F epitope is larger than the linear peptide and restricted to a single protomer in the trimer, whereas motavizumab likely contacts residues on two protomers, indicating a quaternary epitope. Mechanistically, these results suggest that 101F and motavizumab can bind to multiple conformations of the fusion glycoprotein and can neutralize late in the entry process. The structural preservation of neutralizing epitopes in the postfusion state suggests that this conformation can elicit neutralizing antibodies and serve as a useful vaccine antigen.
authors: Vaccine Research Center, NIAID/NIH, 40 Convent Drive, Bldg. 40, Rm. 2613B, Bethesda, MD 20892, USA. mclellanja@mail.nih.gov
authors: Jason S
authors: JS
authors: McLellan
authors: Yongping
authors: Y
authors: Yang
authors: Barney S
authors: BS
authors: Graham
authors: Peter D
authors: PD
authors: Kwong
references: Nat Struct Mol Biol. 2010 Dec;17(12):1486-91
references: 21076402
references: Nature. 1981 Jan 29;289(5796):366-73
references: 7464906
references: Acta Crystallogr D Biol Crystallogr. 2006 Oct;62(Pt 10):1243-50
references: 17001101
references: Nat Struct Mol Biol. 2010 Dec;17(12):1492-4
references: 21076400
references: Cell. 1998 Oct 30;95(3):409-17
references: 9814710
references: Nat Med. 2009 Jan;15(1):34-41
references: 19079256
references: Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17903-8
references: 17093041
references: J Mol Biol. 2007 May 4;368(3):652-65
references: 17362988
references: Am J Epidemiol. 1969 Apr;89(4):422-34
references: 4305198
references: Nat Struct Mol Biol. 2010 Feb;17(2):248-50
references: 20098425
references: Virology. 2002 Jul 5;298(2):317-26
references: 12127793
references: J Appl Crystallogr. 2007 Aug 1;40(Pt 4):658-674
references: 19461840
references: Methods Enzymol. 1997;276:307-26
references: 27754618
references: J Virol. 2010 Aug;84(16):7970-82
references: 20534864
references: Nature. 2006 Jan 5;439(7072):38-44
references: 16397490
references: Proc Natl Acad Sci U S A. 2000 Dec 19;97(26):14172-7
references: 11106388
references: J Virol. 2010 Dec;84(23):12236-44
references: 20881049
references: Pediatrics. 1998 Sep;102(3):531-7
references: 9724660
references: J Gen Virol. 2004 Dec;85(Pt 12):3677-3687
references: 15557241
references: Nature. 1994 Sep 1;371(6492):37-43
references: 8072525
references: J Virol. 1998 Aug;72(8):6922-8
references: 9658147
references: Acta Crystallogr D Biol Crystallogr. 2006 Sep;62(Pt 9):1002-11
references: 16929101
references: J Clin Microbiol. 1988 Aug;26(8):1595-7
references: 2459154
references: Virology. 2010 Jul 5;402(2):372-9
references: 20439109
references: Acta Crystallogr D Biol Crystallogr. 2004 Dec;60(Pt 12 Pt 1):2126-32
references: 15572765
references: J Virol. 1989 Jul;63(7):2941-50
references: 2470922
references: Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):308-13
references: 19966279
references: Acta Crystallogr D Biol Crystallogr. 2002 Nov;58(Pt 11):1948-54
references: 12393927
references: Lancet. 2010 May 1;375(9725):1545-55
references: 20399493
references: Protein Eng. 2002 May;15(5):365-71
references: 12034856
references: J Clin Microbiol. 1986 Aug;24(2):197-202
references: 3755730
references: J Virol. 1988 Nov;62(11):4232-8
references: 2459412
references: Nat Rev Mol Cell Biol. 2003 Apr;4(4):309-19
references: 12671653
references: J Virol. 1983 Jul;47(1):171-7
references: 6345804
references: Virol J. 2006 May 24;3:34
references: 16723026
references: Proc Natl Acad Sci U S A. 2006 May 23;103(21):8060-5
references: 16690741
references: Am J Epidemiol. 1969 Apr;89(4):449-63
references: 4305200
references: Structure. 2001 Mar 7;9(3):255-66
references: 11286892
references: Acta Crystallogr D Biol Crystallogr. 2010 Apr;66(Pt 4):470-8
references: 20383000
references: Proc Natl Acad Sci U S A. 2005 Jun 28;102(26):9288-93
references: 15964978
references: Proc Natl Acad Sci U S A. 1996 Mar 5;93(5):2186-91
references: 8700906
references: Virology. 2000 May 25;271(1):122-31
references: 10814577
references: Am J Epidemiol. 1969 Apr;89(4):405-21
references: 4305197
references: Am J Epidemiol. 1969 Apr;89(4):435-48
references: 4305199
references: J Gen Virol. 1992 Sep;73 ( Pt 9):2225-34
references: 1383404